Basket | Login | Register




In this section you can find all of the articles appearing in our monthly Alzheimer Europe e-newsletters. The newsletters, which aim to keep you informed of developments in the dementia field and to update you on our activities and those of our member organisations can be found on our website for download here.

If you want to receive the e-newsletter, please sign up here.

15/05/2019 World Health Organization (WHO) publishes dementia prevention guidelines
10/05/2019 Jülich completes Phase I trial for its AD drug PRI-002
08/05/2019 The Food and Drug Administration (USA) provides Optina Diagnostics with breakthrough device designation for a new Retinal Imaging Platform
07/05/2019 The Innovative Medicines Initiative funded MOPEAD project publishes project introduction
07/05/2019 Actinogen Medical announces results from its Phase II clinical trial XanADu in AD
07/05/2019 Merck presents positive Phase III data of BELSOMRA® (suvorexant) for the treatment of insomnia in AD
07/05/2019 Study suggests that spatial navigationability may help identify people at high genetic risk of developing AD
06/05/2019 Public-Private consortium publishes the first interactive overview of available outcomes in European data sources for AD research
06/05/2019 Alector announces the recruitment of the first participant in Phase Ib trial of AL002 for AD
06/05/2019 Researchers link cognitive decline in Parkinson’s disease with genetic variants of AD
01/05/2019 Alzheimer Europe welcomes two new colleagues
01/05/2019 Record number of abstracts submitted for 29th Alzheimer Europe Conference
01/05/2019 High-resolution mapping of single brain cells from people with AD identifies early molecular drivers of disease
30/04/2019 Alzheimer Europe Dementia Pledge campaign gathers support from across Europe
30/04/2019 Researchers publish new guidelines for Alzheimer’s disease-like condition